Maplebear Set to Join S&P MidCap 400; Enovis to Join S&P SmallCap 600
Written by Emily J. Thompson, Senior Investment Analyst
Source: PRnewswire
Index Changes Announcement: Maplebear Inc. will replace Enovis Corp. in the S&P MidCap 400, while Enovis will take Arch Resources' place in the S&P SmallCap 600, effective January 14, 2025.
Merger Details: CONSOL Energy is acquiring Arch Resources, with plans to rename itself Core Natural Resources and change its ticker to CNR following the merger's completion.
Analyst Views on ENOV
Wall Street analysts forecast ENOV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ENOV is 49.00 USD with a low forecast of 44.00 USD and a high forecast of 58.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 24.260
Low
44.00
Averages
49.00
High
58.00
Current: 24.260
Low
44.00
Averages
49.00
High
58.00
About ENOV
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
